• Test Usage:
    RAS mutations are commonly found in cancer tissue, causing a permanent activation of the signal transduction pathway downstream of the EGF receptor (EGFR), thus positive signaling for cell growth. Most frequent are KRAS mutations in codons 12,13 in the second (first transcribed) exon. Up to 45% of all colorectal cancer patients exhibit KRAS 12,13 mutations, while another 10-15% may have mutations in KRAS exons 3 and 4 or in the respective regions of the homologous NRAS gene.
  • Report Availability:
    Sample by Tue 11 am; Report Mon
  • Sample Report:
214 Diagnostic Centers found for KRAS & NRAS MUTATION ANALYSIS PANEL in Delhi